Disclosures for "Multimodal Imaging in Black and White People with Multiple Sclerosis on Ocrelizumab: A Pilot Study"
-
Dr. Raghib has nothing to disclose.
-
Fen Bao has nothing to disclose.
-
Eman Dannawey has nothing to disclose.
-
ZL Liaquat has nothing to disclose.
-
Mr. Latif has nothing to disclose.
-
Ms. Santiago-Martinez has nothing to disclose.
-
Mr. Hannawa has received personal compensation for serving as an employee of Genentech. Mr. Hannawa has stock in Genentech.
-
Mrs. Gandhi has nothing to disclose.
-
David Clayton has received personal compensation for serving as an employee of Genentech/Roche. David Clayton has received stock or an ownership interest from Roche. An immediate family member of David Clayton has received publishing royalties from a publication relating to health care.
-
Ajibola Abioye has received personal compensation for serving as an employee of Genentech, Inc.
-
Dr. Rube has nothing to disclose.
-
Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen@Janssen. Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bernitsas has received research support from Roche/Genentech.